The role of IL-37 in human regulatory T cells
The role of IL-37 in human regulatory T cells
批准号:
10298893
负责人:
Mayumi Fujita
金额:
$59.4万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-06 至 2026-06-30
关键词:
Anti-Inflammatory AgentsAntigensApplications GrantsAutoimmunityBindingBiologicalBiologyBlood CellsCASP1 geneCell LineCell NucleusCell physiologyCellsClinicalClinical MedicineComplexDNADataDendritic CellsExposure toFOXP3 geneFailureFamily memberFoundationsGenerationsGenetic TranscriptionGraft RejectionHeterogeneityHomeostasisHumanHuman EngineeringIL2RA geneImmuneImmune ToleranceImmune systemImmunosuppressionIn VitroIndividualInflammasomeInflammatoryInterleukin-1InvestigationLaboratory miceLeadMADH2 geneMADH3 geneMaintenanceMediatingMessenger RNAMolecularMusPathologyPatient CarePharmacologyPhenotypeProcessRegulatory T-LymphocyteReportingRoleSignal PathwaySpecies SpecificityT-LymphocyteT-Lymphocyte SubsetsTestingTherapeuticTranscriptional RegulationTransgenic MiceTransgenic OrganismsTranslatingTranslational RegulationTransplantationTumor Immunityadaptive immune responsecell typecellular engineeringclinical applicationcytokineexposed human populationextracellularforkhead proteinhuman diseasehumanized mousein vivomembermouse modelmutantoverexpressionperipheral bloodperipheral tolerancephenotypic biomarkerpreventpromoterprotein complextissue injurytooltranscription factortranslational impact
中文摘要
项目总结/摘要
理解外周耐受性和维持免疫系统稳态在免疫治疗中是至关重要的。
控制人类疾病。我们以前已经证明,抗炎细胞因子IL-37
参与免疫耐受,通过在抗原诱导下产生半成熟致耐受性树突状细胞(DC),
特异性适应性免疫反应。IL-37是IL-1家族11个成员之一,也是目前已知的唯一一个
广泛的抗炎作用。在我们最近的项目中,我们发现IL-37水平在多个人中升高,
免疫细胞类型,特别是在调节性T细胞(T细胞)中。进一步的分析显示,人类Treg
在所有T细胞亚群中,细胞表达最高的IL-37水平,
与人Treg细胞中主要转录调节因子FOXP 3的表达相关。我们目前
该项目假设IL-37表达升高可稳定Treg细胞并诱导有效的免疫应答。
通过控制FOXP 3表达抑制。IL-37在小鼠中不表达,但使用转基因小鼠和
从人类供体的外周血T细胞中,我们产生了强有力的初步数据来支持我们的假设。
在这项拨款提案中,我们将使用过表达IL-37及其受体的人原代Treg细胞和T细胞系。
IL-37的突变体形式,以阐明IL-37控制人Treg细胞的生物学和分子机制
功能由于我们的提案使用人类T细胞,因此结果可以很容易地转化为临床医学
和病人护理。我们的发现将对许多人类疾病产生巨大的转化影响,
自身免疫和移植。
英文摘要
PROJECT SUMMARY/ABSTRACT
Understanding peripheral tolerance and the maintenance of immune system homeostasis are vital in the
control of human diseases. We have previously demonstrated that anti-inflammatory cytokine IL-37
participates in immune tolerance by generating semi-mature tolerogenic dendritic cells (DCs) in antigen-
specific adaptive immune responses. IL-37 is one of eleven IL-1 family members and the only known member
to be broadly anti-inflammatory. In our recent project, we found IL-37 levels were elevated in multiple human
immune cell types, specifically in regulatory T cells (Tregs) cells. Further analysis revealed that human Treg
cells express the highest IL-37 levels among all T-cell subsets and that intracellular expression of IL-37
correlates with the expression of master transcriptional regulator, FOXP3, in human Treg cells. Our current
project hypothesizes that elevated IL-37 expression stabilizes Treg cells and induces potent immune
suppression by controlling FOXP3 expression. IL-37 is not expressed in mice, but using transgenic mice and
peripheral blood T cells from human donors, we generated strong preliminary data to support our hypothesis.
In this grant proposal, we will use human primary Treg cells and T cell lines overexpressing IL-37 and its
mutant form to elucidate the biological and molecular mechanisms of IL-37 in controlling human Treg cell
function. Since our proposal uses human T cells, the results could be easily translated into clinical medicine
and patient care. Our findings will have an immense translational impact on many human diseases such as
autoimmunity and transplantation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ethanol-induced skin changes
-
批准号:10478153
-
项目类别:
-
资助金额:$18.47万
-
财政年份:2021
-
负责人:Mayumi Fujita
-
依托单位:
Ethanol-induced skin changes
-
批准号:10304053
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2021
-
负责人:Mayumi Fujita
-
依托单位:
The role of IL-37 in human regulatory T cells
-
批准号:10652366
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2021
-
负责人:Mayumi Fujita
-
依托单位:
The role of IL-37 in human regulatory T cells
-
批准号:10445346
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2021
-
负责人:Mayumi Fujita
-
依托单位:
Modulation of Inflammasome-mediated cytokine activation by EGCG in human melanoma
-
批准号:9462554
-
项目类别:
-
资助金额:$4.97万
-
财政年份:2016
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:10451489
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:8698262
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:8334977
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:8511336
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:8803260
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Autoinflammation in Human Melanoma
-
批准号:10045562
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mayumi Fujita
-
依托单位:
Developing a protocol for profiling blood markers of melanoma
-
批准号:7546951
-
项目类别:
-
资助金额:$7.7万
-
财政年份:2008
-
负责人:Mayumi Fujita
-
依托单位:
Developing a protocol for profiling blood markers of melanoma
-
批准号:7685271
-
项目类别:
-
资助金额:$7.67万
-
财政年份:2008
-
负责人:Mayumi Fujita
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: